Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3316629 | Pancreatology | 2016 | 8 Pages |
Abstract
All patients with intra- or post-operative evidence of invasive carcinoma at the resection margin should undergo further resection to achieve a negative margin. Patients with evidence of IPMN at the transaction margin (even with changes of high grade dysplasia/CIS) may not achieve any benefit from further resection. Patients with recurrence in benign/non-invasive IPMN should undergo re-resection, whereas patients with recurrence in invasive IPMN should not.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Neil Bhardwaj, Ashley R. Dennison, Guy J. Maddern, Giuseppe Garcea,